There will be a separate session on Atryn by Leo/GTCB. See Page 7 of the link. <A HREF="http://www.isth2007.com/final/Lunch_Sessions.pdf" target="_blank">http://www.isth2007.com/final/Lunch_Sessions.pdf</A> GTC Biotherapeutics / LEO Pharma <b>ATryn®, the first recombinant antithrombin; innovation or alternative? </b> Chairperson: M. von Depka <b>Introduction & Welcome </b> M. von Depka 13:00 - 13:05 <b>The transgenic production system; an emphasis on safety & purity </b> H. Meade 13:05 - 13:20 <b>ATryn®, an alternative to plasma derived antithrombin</b> M. von Depka 13:20 - 13:35 Discussion Chairpersons and Faculty 13:35 - 13:45